4//SEC Filing
China Biologic Products, Inc. 4
Accession 0001144204-15-060242
CIK 0001369868operating
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:31 PM ET
Size
7.5 KB
Accession
0001144204-15-060242
Insider Transaction Report
Form 4
Gao David
Director
Transactions
- Sale
Common Stock
2015-10-19$105.03/sh−200$21,005→ 616,800 total - Sale
Common Stock
2015-10-20$105.00/sh−258$27,090→ 616,542 total
Footnotes (2)
- [F1]Represents 458 shares of common stock sold through a trading plan (the "10b5-1 Plan") adopted by the Reporting Person on September 14, 2015 that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended. The Reporting Person intends to use the proceeds from the sales effected under the 10b5-1 Plan to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $105.020 to $105.030, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 2.
Documents
Issuer
China Biologic Products, Inc.
CIK 0001369868
Entity typeoperating
Related Parties
1- filerCIK 0001369868
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:31 PM ET
- Size
- 7.5 KB